{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:06:53Z","timestamp":1791284813523,"version":"4.1.0"},"reference-count":206,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204886"],"award-info":[{"award-number":["82204886"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82474252"],"award-info":[{"award-number":["82474252"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2022QH133"],"award-info":[{"award-number":["ZR2022QH133"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Renal fibrosis (RF), as a critical pathological process in the progression of chronic kidney disease (CKD) to end-stage renal disease, currently lacks clear and effective reversal measures. Disordered fatty acid metabolism is highly involved in this process. Studies have revealed that molecular crosstalk under fatty acid metabolism dysregulation\u2014such as lipotoxicity, mitochondrial damage, immune inflammation, epigenetics, metabolic reprogramming, and the gut-kidney axis\u2014drives damage to renal tubules, glomeruli, and the interstitium. Therapeutic strategies targeting fatty acid metabolism to ameliorate RF have gradually become a research hotspot, though most current drugs are still in the clinical exploration stage, and the predictive and therapeutic value of many biomarkers remains to be validated. Traditional Chinese Medicine (TCM), with its personalized and modernized approach combining oral administration and external treatments such as acupuncture, enema, and nanodelivery, is increasingly demonstrating advantages in targeting fatty acid metabolism to improve RF. This review outlines the mechanisms and core targets of TCM in regulating fatty acid metabolism to ameliorate RF. The multi-target advantage based on complex components presents an opportunity for TCM to improve RF, though current research still faces challenges such as mechanistic complexity, standardization of TCM, and clinical translation. Future efforts should integrate multi-omics technologies, novel drug delivery systems, and disease-syndrome combination models to advance the development of new integrated Chinese and Western medicine drugs for RF.<\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1186\/s13020-026-01328-w","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T07:29:17Z","timestamp":1768980557000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Fatty acid metabolism: opportunities and challenges of traditional Chinese medicine in the treatment of renal fibrosis"],"prefix":"10.1186","volume":"21","author":[{"given":"Ran-ran","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"1328_CR1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.mam.2018.06.002","volume":"65","author":"S Djudjaj","year":"2019","unstructured":"Djudjaj S, Boor P. Cellular and molecular mechanisms of kidney fibrosis. Mol Aspects Med Mol Aspects Med. 2019;65:16\u201336. https:\/\/doi.org\/10.1016\/j.mam.2018.06.002.","journal-title":"Mol Aspects Med Mol Aspects Med"},{"key":"1328_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01379-7","volume":"8","author":"R Huang","year":"2023","unstructured":"Huang R, Fu P, Ma L. Kidney fibrosis: from mechanisms to therapeutic medicines. Signal Transduct Target Ther. 2023;8:129. https:\/\/doi.org\/10.1038\/s41392-023-01379-7.","journal-title":"Signal Transduct Target Ther"},{"key":"1328_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01036-5","volume":"7","author":"Q Yuan","year":"2022","unstructured":"Yuan Q, Tang B, Zhang C. Signaling pathways of chronic kidney diseases, implications for therapeutics. Signal Transduct Target Ther. 2022;7:182. https:\/\/doi.org\/10.1038\/s41392-022-01036-5.","journal-title":"Signal Transduct Target Ther"},{"key":"1328_CR4","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41581-023-00741-w","volume":"19","author":"A Mitrofanova","year":"2023","unstructured":"Mitrofanova A, Merscher S, Fornoni A. Kidney lipid dysmetabolism and lipid droplet accumulation in chronic kidney disease. Nat Rev Nephrol. 2023;19:629\u201345. https:\/\/doi.org\/10.1038\/s41581-023-00741-w.","journal-title":"Nat Rev Nephrol"},{"key":"1328_CR5","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1681\/ASN.0000000000000328","volume":"35","author":"H Chen","year":"2024","unstructured":"Chen H, You R, Guo J, et al. WWP2 regulates renal fibrosis and the metabolic reprogramming of profibrotic myofibroblasts. J Am Soc Nephrol. 2024;35:696\u2013718. https:\/\/doi.org\/10.1681\/ASN.0000000000000328.","journal-title":"J Am Soc Nephrol"},{"key":"1328_CR6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nm.3762","volume":"21","author":"HM Kang","year":"2014","unstructured":"Kang HM, Ahn SH, Choi P, et al. Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development. Nat Med. 2014;21:37\u201346. https:\/\/doi.org\/10.1038\/nm.3762.","journal-title":"Nat Med"},{"key":"1328_CR7","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nrneph.2015.215","volume":"12","author":"D Zhou","year":"2015","unstructured":"Zhou D, Liu Y. Renal fibrosis in 2015: understanding the mechanisms of kidney fibrosis. Nat Rev Nephrol. 2015;12:68\u201370. https:\/\/doi.org\/10.1038\/nrneph.2015.215.","journal-title":"Nat Rev Nephrol"},{"key":"1328_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-017-0771-9","volume":"19","author":"F Zhang","year":"2017","unstructured":"Zhang F, Liu H, Liu D, et al. Effects of RAAS inhibitors in patients with kidney disease. Curr Hypertens Rep. 2017;19:72. https:\/\/doi.org\/10.1007\/s11906-017-0771-9.","journal-title":"Curr Hypertens Rep"},{"key":"1328_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2022.108330","volume":"242","author":"J Solomon","year":"2023","unstructured":"Solomon J, Festa MC, Chatzizisis YS, et al. Sodium-glucose co-transporter 2 inhibitors in patients with chronic kidney disease. Pharmacol Ther. 2023;242:108330. https:\/\/doi.org\/10.1016\/j.pharmthera.2022.108330.","journal-title":"Pharmacol Ther"},{"key":"1328_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00967","volume":"11","author":"D Kawanami","year":"2020","unstructured":"Kawanami D, Takashi Y. GLP-1 receptor agonists in diabetic kidney disease: from clinical outcomes to mechanisms. Front Pharmacol. 2020;11:967. https:\/\/doi.org\/10.3389\/fphar.2020.00967.","journal-title":"Front Pharmacol"},{"key":"1328_CR11","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2220\/biomedres.46.83","volume":"46","author":"Y Wang","year":"2025","unstructured":"Wang Y, Liu Q, Zheng Z, et al. Finerenone alleviates the high glucose-induced fibrosis in HK-2 cells by inhibiting EMT via the TGF-\u03b21\/smads signaling. Biomed Res. 2025;46:83\u201392. https:\/\/doi.org\/10.2220\/biomedres.46.83.","journal-title":"Biomed Res"},{"key":"1328_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24097719","volume":"24","author":"W Fujii","year":"2023","unstructured":"Fujii W, Shibata S. Mineralocorticoid receptor antagonists for preventing chronic kidney disease progression: current evidence and future challenges. Int J Mol Sci. 2023;24:7719. https:\/\/doi.org\/10.3390\/ijms24097719.","journal-title":"Int J Mol Sci"},{"key":"1328_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13071881","volume":"13","author":"AB Reiss","year":"2024","unstructured":"Reiss AB, Jacob B, Zubair A, et al. Fibrosis in chronic kidney disease: pathophysiology and therapeutic targets. J Clin Med. 2024;13:1881. https:\/\/doi.org\/10.3390\/jcm13071881.","journal-title":"J Clin Med"},{"key":"1328_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25073969","volume":"25","author":"A Mazzieri","year":"2024","unstructured":"Mazzieri A, Porcellati F, Timio F, et al. Molecular targets of novel therapeutics for diabetic kidney disease: a new era of nephroprotection. Int J Mol Sci. 2024;25:3969. https:\/\/doi.org\/10.3390\/ijms25073969.","journal-title":"Int J Mol Sci"},{"key":"1328_CR15","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.matbio.2017.12.013","volume":"68\u201369","author":"H Fran\u00e7ois","year":"2018","unstructured":"Fran\u00e7ois H, Chatziantoniou C. Renal fibrosis: recent translational aspects. Matrix Biol. 2018;68\u201369:318\u201332. https:\/\/doi.org\/10.1016\/j.matbio.2017.12.013.","journal-title":"Matrix Biol"},{"key":"1328_CR16","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/978-981-13-8871-2_31","volume":"1165","author":"F Liu","year":"2019","unstructured":"Liu F, Zhuang S. New therapies for the treatment of renal fibrosis. Adv Exp Med Biol. 2019;1165:625\u201359. https:\/\/doi.org\/10.1007\/978-981-13-8871-2_31.","journal-title":"Adv Exp Med Biol"},{"key":"1328_CR17","doi-asserted-by":"publisher","first-page":"228","DOI":"10.13422\/j.cnki.syfjx.20231395","volume":"29","author":"GAO Ranran","year":"2023","unstructured":"Ranran GAO, Zhen S, Menghui L, et al. Astragali radix-salviae miltiorrhizae radix et rhizoma mitigate renal fibrosis: a review. Chin J Exp Trad Med Formulae. 2023;29:228\u201336. https:\/\/doi.org\/10.13422\/j.cnki.syfjx.20231395.","journal-title":"Chin J Exp Trad Med Formulae"},{"key":"1328_CR18","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1080\/13880209.2024.2345080","volume":"62","author":"X Dong","year":"2024","unstructured":"Dong X, Zhang J, Li W, et al. Yi-shen-hua-shi regulates intestinal microbiota dysbiosis and protects against proteinuria in patients with chronic kidney disease: a randomized controlled study. Pharm Biol. 2024;62:356\u201366. https:\/\/doi.org\/10.1080\/13880209.2024.2345080.","journal-title":"Pharm Biol"},{"key":"1328_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01117","volume":"9","author":"K-C Huang","year":"2018","unstructured":"Huang K-C, Su Y-C, Sun M-F, et al. Chinese herbal medicine improves the long-term survival rate of patients with chronic kidney disease in taiwan: a nationwide retrospective population-based cohort study. Front Pharmacol. 2018;9:1117. https:\/\/doi.org\/10.3389\/fphar.2018.01117.","journal-title":"Front Pharmacol"},{"key":"1328_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154873","volume":"116","author":"R Li","year":"2023","unstructured":"Li R, Shi C, Wei C, Wang C, et al. Fufang shenhua tablet inhibits renal fibrosis by inhibiting PI3K\/AKT. Phytomedicine. 2023;116:154873. https:\/\/doi.org\/10.1016\/j.phymed.2023.154873.","journal-title":"Phytomedicine"},{"key":"1328_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114989","volume":"164","author":"X Huang","year":"2023","unstructured":"Huang X, Gao L, Deng R, et al. Huangqi-danshen decoction reshapes renal glucose metabolism profiles that delays chronic kidney disease progression. Biomed Pharmacother. 2023;164:114989. https:\/\/doi.org\/10.1016\/j.biopha.2023.114989.","journal-title":"Biomed Pharmacother"},{"key":"1328_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.117189","volume":"319","author":"Y Liu","year":"2024","unstructured":"Liu Y, Wu J, Liang S, et al. Guben xiezhuo decoction inhibits M1 polarization through the Raf1\/p-Elk1 signaling axis to attenuate renal interstitial fibrosis. J Ethnopharmacol. 2024;319:117189. https:\/\/doi.org\/10.1016\/j.jep.2023.117189.","journal-title":"J Ethnopharmacol"},{"key":"1328_CR23","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1007\/s43657-022-00060-3","volume":"2","author":"J Luo","year":"2022","unstructured":"Luo J, Shen S, Xia J, et al. Mitochondria as the essence of yang qi in the human body. Phenomics. 2022;2:336\u201348. https:\/\/doi.org\/10.1007\/s43657-022-00060-3.","journal-title":"Phenomics"},{"key":"1328_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s13020-025-01196-w","volume":"20","author":"Y Wang","year":"2025","unstructured":"Wang Y, Yang L, Sun H, et al. Pathological characteristics of traditional Chinese medicine shi zheng and related therapeutic formula, effective compounds: a general review. Chin Med. 2025;20:214. https:\/\/doi.org\/10.1186\/s13020-025-01196-w.","journal-title":"Chin Med"},{"key":"1328_CR25","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/s0254-6272(13)60024-2","volume":"32","author":"L Zhang","year":"2012","unstructured":"Zhang L, Li W, Sun W. Effect of yishen huayu fang on kidney tissue E-cadherin expression in unilateral ureter ligation in rats. J Tradit Chin Med. 2012;32:273\u20137. https:\/\/doi.org\/10.1016\/s0254-6272(13)60024-2.","journal-title":"J Tradit Chin Med"},{"key":"1328_CR26","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.3969\/j.issn.1008-8849.2023.21.020","volume":"32","author":"X Shi","year":"2023","unstructured":"Shi X, Chang M, Zhao M, et al. Construction of traditional Chinese medicine complex pathogenesis network for chronic nephritis with \u201cDeficiency Wind Stasis Poison\u201d and its modern biological basis. Modern J Integr Tradit Chin Western Med. 2023;32:3027\u201331. https:\/\/doi.org\/10.3969\/j.issn.1008-8849.2023.21.020.","journal-title":"Modern J Integr Tradit Chin Western Med"},{"key":"1328_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/nu11040722","volume":"11","author":"Z Gai","year":"2019","unstructured":"Gai Z, Wang T, Visentin M, et al. Lipid accumulation and chronic kidney disease. Nutrients. 2019;11:722. https:\/\/doi.org\/10.3390\/nu11040722.","journal-title":"Nutrients"},{"key":"1328_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202405325","volume":"11","author":"L Zhang","year":"2024","unstructured":"Zhang L, Tian M, Zhang M, et al. Forkhead box protein K1 promotes chronic kidney disease by driving glycolysis in tubular epithelial cells. Adv Sci. 2024;11:e2405325. https:\/\/doi.org\/10.1002\/advs.202405325.","journal-title":"Adv Sci"},{"issue":"5","key":"1328_CR29","doi-asserted-by":"publisher","DOI":"10.1172\/JCI140695","volume":"131","author":"V Miguel","year":"2021","unstructured":"Miguel V, Titua\u00f1a J, Herrero JI, et al. Renal tubule Cpt1a overexpression protects from kidney fibrosis by restoring mitochondrial homeostasis. J Clin Invest. 2021;131(5):e140695. https:\/\/doi.org\/10.1172\/JCI140695.","journal-title":"J Clin Invest"},{"key":"1328_CR30","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1146\/annurev-physiol-021115-105045","volume":"78","author":"SM Houten","year":"2016","unstructured":"Houten SM, Violante S, Ventura FV, et al. The biochemistry and physiology of mitochondrial fatty acid \u03b2-oxidation and its genetic disorders. Annu Rev Physiol. 2016;78:23\u201344. https:\/\/doi.org\/10.1146\/annurev-physiol-021115-105045.","journal-title":"Annu Rev Physiol"},{"key":"1328_CR31","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/s0014-5793(97)00360-8","volume":"407","author":"R Schneider","year":"1997","unstructured":"Schneider R, Brors B, Massow M, et al. Mitochondrial fatty acid synthesis: a relic of endosymbiontic origin and a specialized means for respiration. FEBS Lett. 1997;407:249\u201352. https:\/\/doi.org\/10.1016\/s0014-5793(97)00360-8.","journal-title":"FEBS Lett"},{"key":"1328_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2015.00052","volume":"2","author":"N Simon","year":"2015","unstructured":"Simon N, Hertig A. Alteration of fatty acid oxidation in tubular epithelial cells: from acute kidney injury to renal fibrogenesis. Front Med. 2015;2:52. https:\/\/doi.org\/10.3389\/fmed.2015.00052.","journal-title":"Front Med"},{"key":"1328_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.00065","volume":"7","author":"H-S Jang","year":"2020","unstructured":"Jang H-S, Noh MR, Kim J, et al. Defective mitochondrial fatty acid oxidation and lipotoxicity in kidney diseases. Front Med. 2020;7:65. https:\/\/doi.org\/10.3389\/fmed.2020.00065.","journal-title":"Front Med"},{"key":"1328_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101851","volume":"40","author":"V Miguel","year":"2021","unstructured":"Miguel V, Ramos R, Garc\u00eda-Bermejo L, et al. The program of renal fibrogenesis is controlled by micrornas regulating oxidative metabolism. Redox Biol. 2021;40:101851. https:\/\/doi.org\/10.1016\/j.redox.2020.101851.","journal-title":"Redox Biol"},{"key":"1328_CR35","doi-asserted-by":"publisher","first-page":"121ra18","DOI":"10.1126\/scitranslmed.3003205","volume":"4","author":"BN Chau","year":"2012","unstructured":"Chau BN, Xin C, Hartner J, Ren S, et al. MicroRNA-21 promotes fibrosis of the kidney by silencing metabolic pathways. Sci Transl Med. 2012;4:121ra18. https:\/\/doi.org\/10.1126\/scitranslmed.3003205.","journal-title":"Sci Transl Med"},{"key":"1328_CR36","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/nrm3313","volume":"13","author":"V Rottiers","year":"2012","unstructured":"Rottiers V, N\u00e4\u00e4r AM. Micrornas in metabolism and metabolic disorders. Nat Rev Mol Cell Biol. 2012;13:239\u201350. https:\/\/doi.org\/10.1038\/nrm3313.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1328_CR37","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.131102","volume":"4","author":"NL Price","year":"2019","unstructured":"Price NL, Miguel V, Ding W, et al. Genetic deficiency or pharmacological inhibition of miR-33 protects from kidney fibrosis. JCI Insight. 2019;4:e131102. https:\/\/doi.org\/10.1172\/jci.insight.131102.","journal-title":"JCI Insight"},{"key":"1328_CR38","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1096\/fj.201901599RR","volume":"34","author":"M Fierro-Fern\u00e1ndez","year":"2019","unstructured":"Fierro-Fern\u00e1ndez M, Miguel V, M\u00e1rquez-Exp\u00f3sito L, et al. MiR-9-5p protects from kidney fibrosis by metabolic reprogramming. FASEB J. 2019;34:410\u201331. https:\/\/doi.org\/10.1096\/fj.201901599RR.","journal-title":"FASEB J"},{"key":"1328_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-024-02248-x","volume":"29","author":"X Wang","year":"2024","unstructured":"Wang X, Gu Z, Huang Y, et al. Microrna-668 alleviates renal fibrosis through PPAR\u03b1\/PGC-1\u03b1 pathway. Eur J Med Res. 2024;29:631. https:\/\/doi.org\/10.1186\/s40001-024-02248-x.","journal-title":"Eur J Med Res"},{"key":"1328_CR40","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1261\/rna.058834.116","volume":"23","author":"R Khurana","year":"2016","unstructured":"Khurana R, Ranches G, Schafferer S, et al. Identification of urinary exosomal noncoding RNAs as novel biomarkers in chronic kidney disease. RNA. 2016;23:142\u201352. https:\/\/doi.org\/10.1261\/rna.058834.116.","journal-title":"RNA"},{"key":"1328_CR41","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1159\/000487104","volume":"139","author":"Y Yu","year":"2018","unstructured":"Yu Y, Bai F, Qin N, et al. Non-proximal renal tubule-derived urinary exosomal miR-200b as a biomarker of renal fibrosis. Nephron. 2018;139:269\u201382. https:\/\/doi.org\/10.1159\/000487104.","journal-title":"Nephron"},{"key":"1328_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-025-04338-x","volume":"16","author":"R Dai","year":"2025","unstructured":"Dai R, Cheng M, Peng C-Y, et al. Renal tubular epithelial cell-derived exosomal miR-330-3p plays a key role in fibroblast activation and renal fibrosis by regulating CREBBP. Stem Cell Res Ther. 2025;16:203. https:\/\/doi.org\/10.1186\/s13287-025-04338-x.","journal-title":"Stem Cell Res Ther"},{"key":"1328_CR43","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1681\/ASN.2017070802","volume":"29","author":"KW Chung","year":"2018","unstructured":"Chung KW, Lee EK, Lee MK, et al. Impairment of PPAR\u03b1 and the fatty acid oxidation pathway aggravates renal fibrosis during aging. J Am Soc Nephrol. 2018;29:1223\u201337. https:\/\/doi.org\/10.1681\/ASN.2017070802.","journal-title":"J Am Soc Nephrol"},{"key":"1328_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04515-3","volume":"13","author":"J Li","year":"2022","unstructured":"Li J, Yang Y, Li Q, et al. STAT6 contributes to renal fibrosis by modulating PPAR\u03b1-mediated tubular fatty acid oxidation. Cell Death Dis. 2022;13:66. https:\/\/doi.org\/10.1038\/s41419-022-04515-3.","journal-title":"Cell Death Dis"},{"key":"1328_CR45","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.freeradbiomed.2022.12.096","volume":"195","author":"L Chen","year":"2023","unstructured":"Chen L, Sha M-L, Chen F-T, et al. Upregulation of KLF14 expression attenuates kidney fibrosis by inducing PPAR\u03b1-mediated fatty acid oxidation. Free Radic Biol Med. 2023;195:132\u201344. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2022.12.096.","journal-title":"Free Radic Biol Med"},{"key":"1328_CR46","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/j.kint.2021.08.031","volume":"100","author":"SE Piret","year":"2021","unstructured":"Piret SE, Attallah AA, Gu X, et al. Loss of proximal tubular transcription factor kr\u00fcppel-like factor 15 exacerbates kidney injury through loss of fatty acid oxidation. Kidney Int. 2021;100:1250\u201367. https:\/\/doi.org\/10.1016\/j.kint.2021.08.031.","journal-title":"Kidney Int"},{"key":"1328_CR47","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.kint.2018.09.023","volume":"95","author":"T-M Jao","year":"2019","unstructured":"Jao T-M, Nangaku M, Wu C-H, et al. ATF6\u03b1 downregulation of PPAR\u03b1 promotes lipotoxicity-induced tubulointerstitial fibrosis. Kidney Int. 2019;95:577\u201389. https:\/\/doi.org\/10.1016\/j.kint.2018.09.023.","journal-title":"Kidney Int"},{"key":"1328_CR48","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/ki.2010.530","volume":"79","author":"Y Tanaka","year":"2011","unstructured":"Tanaka Y, Kume S, Araki S, et al. Fenofibrate, a PPAR\u03b1 agonist, has renoprotective effects in mice by enhancing renal lipolysis. Kidney Int. 2011;79:871\u201382. https:\/\/doi.org\/10.1038\/ki.2010.530.","journal-title":"Kidney Int"},{"key":"1328_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24054882","volume":"24","author":"M Son","year":"2023","unstructured":"Son M, Kim GY, Yang Y, et al. PPAR pan agonist MHY2013 alleviates renal fibrosis in a mouse model by reducing fibroblast activation and epithelial inflammation. Int J Mol Sci. 2023;24:4882. https:\/\/doi.org\/10.3390\/ijms24054882.","journal-title":"Int J Mol Sci"},{"key":"1328_CR50","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1507\/endocrj.EJ24-0087","volume":"71","author":"S Nishihara","year":"2024","unstructured":"Nishihara S, Koseki M, Tanaka K, et al. Tofogliflozin attenuates renal lipid deposition and inflammation via PPAR\u03b1 upregulation mediated by miR-21a impairment in diet-induced steatohepatitic mice. Endocr J. 2024;71:1055\u201367. https:\/\/doi.org\/10.1507\/endocrj.EJ24-0087.","journal-title":"Endocr J"},{"key":"1328_CR51","doi-asserted-by":"publisher","first-page":"759","DOI":"10.33549\/physiolres.934411","volume":"69","author":"H Wu","year":"2020","unstructured":"Wu H, Li X, Shen C. Peroxisome proliferator-activated receptor gamma in white and brown adipocyte regulation and differentiation. Physiol Res. 2020;69:759\u201373. https:\/\/doi.org\/10.33549\/physiolres.934411.","journal-title":"Physiol Res"},{"key":"1328_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trsl.2023.07.004","volume":"266","author":"S Lin","year":"2024","unstructured":"Lin S, Wang L, Jia Y, et al. Lipin-1 deficiency deteriorates defect of fatty acid \u03b2-oxidation and lipid-related kidney damage in diabetic kidney disease. Transl Res. 2024;266:1\u201315. https:\/\/doi.org\/10.1016\/j.trsl.2023.07.004.","journal-title":"Transl Res"},{"key":"1328_CR53","doi-asserted-by":"publisher","first-page":"3758","DOI":"10.7150\/thno.71722","volume":"12","author":"L Liu","year":"2022","unstructured":"Liu L, Ning X, Wei L, et al. Twist1 downregulation of PGC-1\u03b1 decreases fatty acid oxidation in tubular epithelial cells, leading to kidney fibrosis. Theranostics. 2022;12:3758\u201375. https:\/\/doi.org\/10.7150\/thno.71722.","journal-title":"Theranostics"},{"key":"1328_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2025.167656","volume":"1871","author":"P Sun","year":"2025","unstructured":"Sun P, Chen Q, Chen X, et al. Renal tubular S100A7a impairs fatty acid oxidation and exacerbates renal fibrosis via both intracellular and extracellular pathway. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2025;1871:167656. https:\/\/doi.org\/10.1016\/j.bbadis.2025.167656.","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"},{"key":"1328_CR55","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.kint.2025.02.009","volume":"107","author":"Y Wang","year":"2025","unstructured":"Wang Y, Zeng Y, Fu Y, et al. Repression of peroxisome proliferation-activated receptor \u03b3 coactivator-1\u03b1 by p53 after kidney injury promotes mitochondrial damage and maladaptive kidney repair. Kidney Int. 2025;107:869\u201387. https:\/\/doi.org\/10.1016\/j.kint.2025.02.009.","journal-title":"Kidney Int"},{"issue":"1","key":"1328_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04480-3","volume":"13","author":"BY Nam","year":"2022","unstructured":"Nam BY, Jhee JH, Park J, et al. PGC-1\u03b1 inhibits the NLRP3 inflammasome via preserving mitochondrial viability to protect kidney fibrosis. Cell Death Dis. 2022;13(1):31. https:\/\/doi.org\/10.1038\/s41419-021-04480-3.","journal-title":"Cell Death Dis"},{"key":"1328_CR57","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.cmet.2020.11.011","volume":"33","author":"P Dhillon","year":"2021","unstructured":"Dhillon P, Park J, Hurtado Del Pozo C, et al. The nuclear receptor ESRRA protects from kidney disease by coupling metabolism and differentiation. Cell Metab. 2021;33:379-394.e8. https:\/\/doi.org\/10.1016\/j.cmet.2020.11.011.","journal-title":"Cell Metab"},{"key":"1328_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2022.166572","volume":"1869","author":"C Liu","year":"2023","unstructured":"Liu C, Li S, Ji S, et al. Proximal tubular Bmal1 protects against chronic kidney injury and renal fibrosis by maintaining of cellular metabolic homeostasis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2023;1869:166572. https:\/\/doi.org\/10.1016\/j.bbadis.2022.166572.","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"},{"issue":"2","key":"1328_CR59","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1093\/ndt\/gfw333","volume":"32","author":"N Simon-Tillaux","year":"2016","unstructured":"Simon-Tillaux N, Hertig A. Snail and kidney fibrosis. Nephrol Dial Transplant. 2016;32(2):224\u201333. https:\/\/doi.org\/10.1093\/ndt\/gfw333.","journal-title":"Nephrol Dial Transplant"},{"key":"1328_CR60","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/nm.3901","volume":"21","author":"MT Grande","year":"2015","unstructured":"Grande MT, S\u00e1nchez-Laorden B, L\u00f3pez-Blau C, et al. Snail1-induced partial epithelial-to-mesenchymal transition drives renal fibrosis in mice and can be targeted to reverse established disease. Nat Med. 2015;21:989\u201397. https:\/\/doi.org\/10.1038\/nm.3901.","journal-title":"Nat Med"},{"key":"1328_CR61","doi-asserted-by":"publisher","first-page":"eaaz597","DOI":"10.1126\/scisignal.aaz2597","volume":"13","author":"S Lovisa","year":"2020","unstructured":"Lovisa S, Fletcher-Sananikone E, Sugimoto H, et al. Endothelial-to-mesenchymal transition compromises vascular integrity to induce Myc-mediated metabolic reprogramming in kidney fibrosis. Sci Signal. 2020;13:eaaz597. https:\/\/doi.org\/10.1126\/scisignal.aaz2597.","journal-title":"Sci Signal"},{"key":"1328_CR62","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/1276195","volume":"2020","author":"Y Wang","year":"2020","unstructured":"Wang Y, Fu M, Wang J, et al. Qiliqiangxin improves cardiac function through regulating energy metabolism via HIF-1\u03b1-dependent and independent mechanisms in heart failure rats after acute myocardial infarction. BioMed Res Int. 2020;2020:1276195. https:\/\/doi.org\/10.1155\/2020\/1276195.","journal-title":"BioMed Res Int"},{"key":"1328_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.746920","volume":"8","author":"X Zhu","year":"2021","unstructured":"Zhu X, Jiang L, Long M, et al. Metabolic reprogramming and renal fibrosis. Front Med. 2021;8:746920. https:\/\/doi.org\/10.3389\/fmed.2021.746920.","journal-title":"Front Med"},{"key":"1328_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2544-7","volume":"11","author":"T Cai","year":"2020","unstructured":"Cai T, Ke Q, Fang Y, et al. Sodium-glucose cotransporter 2 inhibition suppresses HIF-1\u03b1-mediated metabolic switch from lipid oxidation to glycolysis in kidney tubule cells of diabetic mice. Cell Death Dis. 2020;11:390. https:\/\/doi.org\/10.1038\/s41419-020-2544-7.","journal-title":"Cell Death Dis"},{"key":"1328_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.927329","volume":"13","author":"X Wei","year":"2022","unstructured":"Wei X, Hou Y, Long M, et al. Molecular mechanisms underlying the role of hypoxia-inducible factor-1 \u03b1 in metabolic reprogramming in renal fibrosis. Front Endocrinol. 2022;13:927329. https:\/\/doi.org\/10.3389\/fendo.2022.927329.","journal-title":"Front Endocrinol"},{"key":"1328_CR66","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.kint.2019.10.020","volume":"97","author":"M Ito","year":"2020","unstructured":"Ito M, Tanaka T, Ishii T, et al. Prolyl hydroxylase inhibition protects the kidneys from ischemia via upregulation of glycogen storage. Kidney Int. 2020;97:687\u2013701. https:\/\/doi.org\/10.1016\/j.kint.2019.10.020.","journal-title":"Kidney Int"},{"key":"1328_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-2219-4","volume":"11","author":"Q Ke","year":"2020","unstructured":"Ke Q, Yuan Q, Qin N, et al. UCP2-induced hypoxia promotes lipid accumulation and tubulointerstitial fibrosis during ischemic kidney injury. Cell Death Dis. 2020;11:26. https:\/\/doi.org\/10.1038\/s41419-019-2219-4.","journal-title":"Cell Death Dis"},{"key":"1328_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.156738","volume":"141","author":"W-M Zhao","year":"2025","unstructured":"Zhao W-M, Chu F, Zhu J-X, et al. Diosmin attenuates UUO-induced renal ferroptosis and fibrosis by inhibiting the HIF-1\u03b1\/FABP4 signaling axis. Phytomedicine. 2025;141:156738. https:\/\/doi.org\/10.1016\/j.phymed.2025.156738.","journal-title":"Phytomedicine"},{"key":"1328_CR69","doi-asserted-by":"publisher","first-page":"bqz046","DOI":"10.1210\/endocr\/bqz046","volume":"161","author":"IR Schlaepfer","year":"2020","unstructured":"Schlaepfer IR, Joshi M. CPT1A-mediated fat oxidation, mechanisms, and therapeutic potential. Mol Endocrinol. 2020;161:bqz046. https:\/\/doi.org\/10.1210\/endocr\/bqz046.","journal-title":"Mol Endocrinol"},{"key":"1328_CR70","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1093\/ndt\/gfu249","volume":"29","author":"MP Martinez Cantarin","year":"2014","unstructured":"Martinez Cantarin MP, Keith SW, Waldman SA, et al. Adiponectin receptor and adiponectin signaling in human tissue among patients with end-stage renal disease. Nephrol Dial Transplant. 2014;29:2268\u201377. https:\/\/doi.org\/10.1093\/ndt\/gfu249.","journal-title":"Nephrol Dial Transplant"},{"key":"1328_CR71","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1039\/c7mb00167c","volume":"13","author":"L Li","year":"2017","unstructured":"Li L, Wang C, Yang H, et al. Metabolomics reveal mitochondrial and fatty acid metabolism disorders that contribute to the development of DKD in T2DM patients. Mol Biosyst. 2017;13:2392\u2013400. https:\/\/doi.org\/10.1039\/c7mb00167c.","journal-title":"Mol Biosyst"},{"key":"1328_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.104600","volume":"152","author":"J Lee","year":"2020","unstructured":"Lee J, Hyon J-Y, Min JY, et al. Mitochondrial carnitine palmitoyltransferase 2 is involved in n\u03b5-(carboxymethyl)-lysine-mediated diabetic nephropathy. Pharmacol Res. 2020;152:104600. https:\/\/doi.org\/10.1016\/j.phrs.2019.104600.","journal-title":"Pharmacol Res"},{"key":"1328_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2023.112139","volume":"582","author":"T Gan","year":"2024","unstructured":"Gan T, Wang Q, Song Y, et al. Canagliflozin improves fatty acid oxidation and ferroptosis of renal tubular epithelial cells via FOXA1-CPT1A axis in diabetic kidney disease. Mol Cell Endocrinol. 2024;582:112139. https:\/\/doi.org\/10.1016\/j.mce.2023.112139.","journal-title":"Mol Cell Endocrinol"},{"key":"1328_CR74","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/nrneph.2017.126","volume":"13","author":"X Yang","year":"2017","unstructured":"Yang X, Okamura DM, Lu X, et al. CD36 in chronic kidney disease: novel insights and therapeutic opportunities. Nat Rev Nephrol. 2017;13:769\u201381. https:\/\/doi.org\/10.1038\/nrneph.2017.126.","journal-title":"Nat Rev Nephrol"},{"key":"1328_CR75","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1002\/jcb.21236","volume":"101","author":"Y-L Yang","year":"2007","unstructured":"Yang Y-L, Lin S-H, Chuang L-Y, et al. CD36 is a novel and potential anti-fibrogenic target in albumin-induced renal proximal tubule fibrosis. J Cell Biochem. 2007;101:735\u201344. https:\/\/doi.org\/10.1002\/jcb.21236.","journal-title":"J Cell Biochem"},{"key":"1328_CR76","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.kint.2015.12.043","volume":"89","author":"ACP Souza","year":"2016","unstructured":"Souza ACP, Bocharov AV, Baranova IN, et al. Antagonism of scavenger receptor CD36 by 5A\u2002peptide prevents chronic kidney disease progression in mice independent of blood pressure\u2002regulation. Kidney Int. 2016;89:809\u201322. https:\/\/doi.org\/10.1016\/j.kint.2015.12.043.","journal-title":"Kidney Int"},{"key":"1328_CR77","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.cmet.2021.04.004","volume":"33","author":"Y Mori","year":"2021","unstructured":"Mori Y, Ajay AK, Chang J-H, et al. KIM-1 mediates fatty acid uptake by renal tubular cells to promote progressive diabetic kidney disease. Cell Metab. 2021;33:1042-1061.e7. https:\/\/doi.org\/10.1016\/j.cmet.2021.04.004.","journal-title":"Cell Metab"},{"key":"1328_CR78","doi-asserted-by":"publisher","DOI":"10.1172\/JCI172963","volume":"134","author":"D Mukhi","year":"2023","unstructured":"Mukhi D, Li L, Liu H, et al. ACSS2 gene variants determine kidney disease risk by controlling de novo lipogenesis in kidney tubules. J Clin Invest. 2023;134:e172963. https:\/\/doi.org\/10.1172\/JCI172963.","journal-title":"J Clin Invest"},{"key":"1328_CR79","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ymeth.2020.06.022","volume":"187","author":"Y Li","year":"2021","unstructured":"Li Y. Modern epigenetics methods in biological research. Methods. 2021;187:104\u201313. https:\/\/doi.org\/10.1016\/j.ymeth.2020.06.022.","journal-title":"Methods"},{"key":"1328_CR80","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-07154-y","volume":"15","author":"S Chen","year":"2024","unstructured":"Chen S, Li J, Liang Y, et al. \u03b2-catenin-inhibited sumoylation modification of LKB1 and fatty acid metabolism is critical in renal fibrosis. Cell Death Dis. 2024;15:769. https:\/\/doi.org\/10.1038\/s41419-024-07154-y.","journal-title":"Cell Death Dis"},{"key":"1328_CR81","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0079815","volume":"8","author":"Y Lu","year":"2013","unstructured":"Lu Y, Zhou Q, Shi Y, et al. SUMOylation of PPAR\u03b3 by rosiglitazone prevents LPS-induced NCoR degradation mediating down regulation of chemokines expression in renal proximal tubular cells. PLoS ONE. 2013;8:e79815. https:\/\/doi.org\/10.1371\/journal.pone.0079815.","journal-title":"PLoS ONE"},{"key":"1328_CR82","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04134-4","volume":"12","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Wen P, Luo J, et al. Sirtuin 3 regulates mitochondrial protein acetylation and metabolism in tubular epithelial cells during renal fibrosis. Cell Death Dis. 2021;12:847. https:\/\/doi.org\/10.1038\/s41419-021-04134-4.","journal-title":"Cell Death Dis"},{"key":"1328_CR83","doi-asserted-by":"publisher","first-page":"5109","DOI":"10.1111\/jcmm.15148","volume":"24","author":"M Li","year":"2020","unstructured":"Li M, Li C-M, Ye Z-C, et al. Sirt3 modulates fatty acid oxidation and attenuates cisplatin-induced AKI in mice. J Cell Mol Med. 2020;24:5109\u201321. https:\/\/doi.org\/10.1111\/jcmm.15148.","journal-title":"J Cell Mol Med"},{"key":"1328_CR84","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.kint.2023.02.009","volume":"103","author":"J Cai","year":"2023","unstructured":"Cai J, Dong Z. Two-way communication between the nucleus and mitochondria via a micropeptide in renal fibrosis. Kidney Int. 2023;103:833\u20135. https:\/\/doi.org\/10.1016\/j.kint.2023.02.009.","journal-title":"Kidney Int"},{"key":"1328_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2023.166701","volume":"1869","author":"L Liu","year":"2023","unstructured":"Liu L, Liu T, Jia R, et al. Downregulation of fatty acid oxidation led by hilpda increases G2\/M arrest\/delay-induced kidney fibrosis. Biochim Biophys Acta Mol Basis Dis. 2023;1869:166701. https:\/\/doi.org\/10.1016\/j.bbadis.2023.166701.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"1328_CR86","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.kint.2016.06.013","volume":"90","author":"HH Szeto","year":"2016","unstructured":"Szeto HH, Liu S, Soong Y, et al. Protection of mitochondria prevents high-fat diet-induced glomerulopathy and proximal tubular\u2002injury. Kidney Int. 2016;90:997\u20131011. https:\/\/doi.org\/10.1016\/j.kint.2016.06.013.","journal-title":"Kidney Int"},{"key":"1328_CR87","doi-asserted-by":"publisher","DOI":"10.3390\/cells14110794","volume":"14","author":"N Pavlovi\u0107","year":"2025","unstructured":"Pavlovi\u0107 N, Kri\u017eanac M, Kumri\u0107 M, et al. Mitochondrial dysfunction: the silent catalyst of kidney disease progression. Cells. 2025;14:794. https:\/\/doi.org\/10.3390\/cells14110794.","journal-title":"Cells"},{"key":"1328_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2023.155718","volume":"150","author":"Z Luo","year":"2024","unstructured":"Luo Z, Chen Z, Hu J, et al. Interplay of lipid metabolism and inflammation in podocyte injury. Metabolism. 2024;150:155718. https:\/\/doi.org\/10.1016\/j.metabol.2023.155718.","journal-title":"Metabolism"},{"key":"1328_CR89","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-022-03300-4","volume":"5","author":"K Matoba","year":"2022","unstructured":"Matoba K, Takeda Y, Nagai Y, et al. ROCK2-induced metabolic rewiring in diabetic podocytopathy. Commun Biol. 2022;5:341. https:\/\/doi.org\/10.1038\/s42003-022-03300-4.","journal-title":"Commun Biol"},{"key":"1328_CR90","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.freeradbiomed.2023.09.039","volume":"209","author":"Q Chen","year":"2023","unstructured":"Chen Q, Xie C, Tang K, et al. The E3 ligase Trim63 promotes podocyte injury and proteinuria by targeting PPAR\u03b1 to inhibit fatty acid oxidation. Free Radic Biol Med. 2023;209:40\u201354. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2023.09.039.","journal-title":"Free Radic Biol Med"},{"key":"1328_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2020.158793","volume":"1865","author":"Y Su","year":"2020","unstructured":"Su Y, Chen Q, Ju Y, et al. Palmitate induces human glomerular mesangial cells fibrosis through CD36-mediated transient receptor potential canonical channel 6\/nuclear factor of activated T cell 2 activation. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 2020;1865:158793. https:\/\/doi.org\/10.1016\/j.bbalip.2020.158793.","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"},{"key":"1328_CR92","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/ki.2015.121","volume":"88","author":"YBY Sun","year":"2015","unstructured":"Sun YBY, Qu X, Howard V, et al. Smad3 deficiency protects mice from obesity-induced podocyte injury that precedes insulin resistance. Kidney Int. 2015;88:286\u201398. https:\/\/doi.org\/10.1038\/ki.2015.121.","journal-title":"Kidney Int"},{"key":"1328_CR93","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1089\/ars.2015.6372","volume":"24","author":"H Yuan","year":"2016","unstructured":"Yuan H, Reddy MA, Deshpande S, et al. Epigenetic histone modifications involved in profibrotic gene regulation by 12\/15-lipoxygenase and its oxidized lipid products in diabetic nephropathy. Antioxid Redox Signal. 2016;24:361\u201375. https:\/\/doi.org\/10.1089\/ars.2015.6372.","journal-title":"Antioxid Redox Signal"},{"key":"1328_CR94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/4074832","volume":"2020","author":"W Huang","year":"2020","unstructured":"Huang W, Man Y, Gao C, et al. Short-chain fatty acids ameliorate diabetic nephropathy via GPR43-mediated inhibition of oxidative stress and NF-\u03baB signaling. Oxid Med Cell Longev. 2020;2020:1\u201321. https:\/\/doi.org\/10.1155\/2020\/4074832.","journal-title":"Oxid Med Cell Longev"},{"key":"1328_CR95","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/7643322","volume":"2022","author":"T Zhou","year":"2022","unstructured":"Zhou T, Xu H, Cheng X, et al. Sodium butyrate attenuates diabetic kidney disease partially via histone butyrylation modification. Mediators Inflamm. 2022;2022:1\u201316. https:\/\/doi.org\/10.1155\/2022\/7643322.","journal-title":"Mediators Inflamm"},{"key":"1328_CR96","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1681\/ASN.2014121271","volume":"27","author":"XX Wang","year":"2015","unstructured":"Wang XX, Edelstein MH, Gafter U, et al. G protein-coupled bile acid receptor TGR5 activation inhibits kidney disease in obesity and diabetes. J Am Soc Nephrol. 2015;27:1362\u201378. https:\/\/doi.org\/10.1681\/ASN.2014121271.","journal-title":"J Am Soc Nephrol"},{"key":"1328_CR97","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/S0002-9440(10)62043-3","volume":"167","author":"K Rodgers","year":"2005","unstructured":"Rodgers K, McMahon B, Mitchell D, et al. Lipoxin A4 modifies platelet-derived growth factor-induced pro-fibrotic gene expression in human renal mesangial cells. Am J Pathol. 2005;167:683\u201394. https:\/\/doi.org\/10.1016\/S0002-9440(10)62043-3.","journal-title":"Am J Pathol"},{"key":"1328_CR98","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1093\/ndt\/gfad238","volume":"39","author":"ME Jacobs","year":"2023","unstructured":"Jacobs ME, de Vries DK, Engelse MA, et al. Endothelial to mesenchymal transition in kidney fibrosis. Nephrol Dial Transplant. 2023;39:752\u201360. https:\/\/doi.org\/10.1093\/ndt\/gfad238.","journal-title":"Nephrol Dial Transplant"},{"key":"1328_CR99","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.566535","volume":"11","author":"Y Feng","year":"2020","unstructured":"Feng Y, Guo F, Xia Z, et al. Inhibition of fatty acid-binding protein 4 attenuated kidney fibrosis by mediating macrophage-to-myofibroblast transition. Front Immunol. 2020;11:566535. https:\/\/doi.org\/10.3389\/fimmu.2020.566535.","journal-title":"Front Immunol"},{"key":"1328_CR100","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2023.101712","volume":"71","author":"Y Gui","year":"2023","unstructured":"Gui Y, Wang Y, Palanza Z, et al. Calponin 2 harnesses metabolic reprogramming to determine kidney fibrosis. Mol Metab. 2023;71:101712. https:\/\/doi.org\/10.1016\/j.molmet.2023.101712.","journal-title":"Mol Metab"},{"key":"1328_CR101","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21228827","volume":"21","author":"MJ Rodr\u00edguez","year":"2020","unstructured":"Rodr\u00edguez MJ, Herrera F, Donoso W, et al. Pro-resolving lipid mediator resolvin E1 mitigates the progress of diethylnitrosamine-induced liver fibrosis in sprague-dawley rats by attenuating fibrogenesis and restricting proliferation. Int J Mol Sci. 2020;21:8827. https:\/\/doi.org\/10.3390\/ijms21228827.","journal-title":"Int J Mol Sci"},{"key":"1328_CR102","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1002\/path.4050","volume":"228","author":"X Qu","year":"2012","unstructured":"Qu X, Zhang X, Yao J, et al. Resolvins E1 and D1 inhibit interstitial fibrosis in the obstructed kidney via inhibition of local fibroblast proliferation. J Pathol. 2012;228:506\u201319. https:\/\/doi.org\/10.1002\/path.4050.","journal-title":"J Pathol"},{"key":"1328_CR103","doi-asserted-by":"publisher","first-page":"4243","DOI":"10.26355\/eurrev_201807_15419","volume":"22","author":"X-N Yin","year":"2018","unstructured":"Yin X-N, Wang J, Cui L-F, et al. Enhanced glycolysis in the process of renal fibrosis aggravated the development of chronic kidney disease. Eur Rev Med Pharmacol Sci. 2018;22:4243\u201351. https:\/\/doi.org\/10.26355\/eurrev_201807_15419.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1328_CR104","doi-asserted-by":"publisher","first-page":"F561","DOI":"10.1152\/ajprenal.00036.2017","volume":"313","author":"H Ding","year":"2017","unstructured":"Ding H, Jiang L, Xu J, et al. Inhibiting aerobic glycolysis suppresses renal interstitial fibroblast activation and renal fibrosis. Am J Physiol Renal Physiol. 2017;313:F561\u201375. https:\/\/doi.org\/10.1152\/ajprenal.00036.2017.","journal-title":"Am J Physiol Renal Physiol"},{"key":"1328_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119206","volume":"272","author":"H Yu","year":"2021","unstructured":"Yu H, Zhu J, Chang L, et al. 3-bromopyruvate decreased kidney fibrosis and fibroblast activation by suppressing aerobic glycolysis in unilateral ureteral obstruction mice model. Life Sci. 2021;272:119206. https:\/\/doi.org\/10.1016\/j.lfs.2021.119206.","journal-title":"Life Sci"},{"key":"1328_CR106","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03199-x","volume":"11","author":"Y Chen","year":"2020","unstructured":"Chen Y, Yan Q, Lv M, et al. Involvement of FATP2-mediated tubular lipid metabolic reprogramming in renal fibrogenesis. Cell Death Dis. 2020;11:994. https:\/\/doi.org\/10.1038\/s41419-020-03199-x.","journal-title":"Cell Death Dis"},{"key":"1328_CR107","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.202101105","volume":"66","author":"H Kim","year":"2022","unstructured":"Kim H, Nam BY, Park J, et al. Lactobacillus acidophilus KBL409 reduces kidney fibrosis via immune modulatory effects in mice with chronic kidney disease. Mol Nutr Food Res. 2022;66:e2101105. https:\/\/doi.org\/10.1002\/mnfr.202101105.","journal-title":"Mol Nutr Food Res"},{"key":"1328_CR108","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s10157-016-1365-6","volume":"21","author":"K Kawaoka","year":"2016","unstructured":"Kawaoka K, Doi S, Nakashima A, et al. Valproic acid attenuates renal fibrosis through the induction of autophagy. Clin Exp Nephrol. 2016;21:771\u201380. https:\/\/doi.org\/10.1007\/s10157-016-1365-6.","journal-title":"Clin Exp Nephrol"},{"key":"1328_CR109","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1681\/ASN.2019101029","volume":"31","author":"YJ Li","year":"2020","unstructured":"Li YJ, Chen X, Kwan TK, et al. Dietary fiber protects against diabetic nephropathy through short-chain fatty acid-mediated activation of G protein-coupled receptors GPR43 and GPR109A. J Am Soc Nephrol. 2020;31:1267\u201381. https:\/\/doi.org\/10.1681\/ASN.2019101029.","journal-title":"J Am Soc Nephrol"},{"key":"1328_CR110","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41577-024-01014-8","volume":"24","author":"ER Mann","year":"2024","unstructured":"Mann ER, Lam YK, Uhlig HH. Short-chain fatty acids: Linking diet, the microbiome and immunity. Nat Rev Immunol. 2024;24:577\u201395. https:\/\/doi.org\/10.1038\/s41577-024-01014-8.","journal-title":"Nat Rev Immunol"},{"key":"1328_CR111","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/978-0-387-69080-3_61","volume":"617","author":"C Chung","year":"2008","unstructured":"Chung C, Doll JA, Stellmach VM, et al. Pigment epithelium-derived factor is an angiogenesis and lipid regulator that activates peroxisome proliferator-activated receptor alpha. Adv Exp Med Biol. 2008;617:591\u20137. https:\/\/doi.org\/10.1007\/978-0-387-69080-3_61.","journal-title":"Adv Exp Med Biol"},{"key":"1328_CR112","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.kint.2021.04.037","volume":"100","author":"IM Schmidt","year":"2021","unstructured":"Schmidt IM, Colona MR, Kestenbaum BR, et al. Cadherin-11, sparc-related modular calcium binding protein-2, and pigment epithelium-derived factor are promising non-invasive biomarkers of kidney fibrosis. Kidney Int. 2021;100:672\u201383. https:\/\/doi.org\/10.1016\/j.kint.2021.04.037.","journal-title":"Kidney Int"},{"key":"1328_CR113","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1080\/10408363.2021.1879000","volume":"58","author":"Y Wen","year":"2021","unstructured":"Wen Y, Parikh CR. Current concepts and advances in biomarkers of acute kidney injury. Crit Rev Clin Lab Sci. 2021;58:354\u201368. https:\/\/doi.org\/10.1080\/10408363.2021.1879000.","journal-title":"Crit Rev Clin Lab Sci"},{"key":"1328_CR114","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109501","volume":"36","author":"D Aguilar-Recarte","year":"2021","unstructured":"Aguilar-Recarte D, Barroso E, Gum\u00e0 A, et al. GDF15 mediates the metabolic effects of PPAR\u03b2\/\u03b4 by activating AMPK. Cell Rep. 2021;36:109501. https:\/\/doi.org\/10.1016\/j.celrep.2021.109501.","journal-title":"Cell Rep"},{"key":"1328_CR115","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.0000000767","author":"A Onoja","year":"2025","unstructured":"Onoja A, McDonnell T, Annessi I, et al. Biomarkers of kidney failure and all-cause mortality in CKD. J Am Soc Nephrol. 2025. https:\/\/doi.org\/10.1681\/ASN.0000000767.","journal-title":"J Am Soc Nephrol"},{"key":"1328_CR116","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-04974-6","volume":"22","author":"M He","year":"2024","unstructured":"He M, Wei W, Zhang Y, et al. Gut microbial metabolites SCFAs and chronic kidney disease. J Transl Med. 2024;22:172. https:\/\/doi.org\/10.1186\/s12967-024-04974-6.","journal-title":"J Transl Med"},{"key":"1328_CR117","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33824-6","volume":"13","author":"W Zhou","year":"2022","unstructured":"Zhou W, Wu W-H, Si Z-L, et al. The gut microbe bacteroides fragilis ameliorates renal fibrosis in mice. Nat Commun. 2022;13:6081. https:\/\/doi.org\/10.1038\/s41467-022-33824-6.","journal-title":"Nat Commun"},{"key":"1328_CR118","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.156582","volume":"140","author":"R-R Gao","year":"2025","unstructured":"Gao R-R, Han C, Sui G-Y, et al. Huangqi and danshen improve the chronic nephrotoxicity of cyclosporin a by regulating lipid metabolism. Phytomedicine. 2025;140:156582. https:\/\/doi.org\/10.1016\/j.phymed.2025.156582.","journal-title":"Phytomedicine"},{"key":"1328_CR119","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-024-01226-4","volume":"14","author":"J Liu","year":"2024","unstructured":"Liu J, Wang H, Liu Q, et al. Klotho exerts protection in chronic kidney disease associated with regulating inflammatory response and lipid metabolism. Cell Biosci. 2024;14:46. https:\/\/doi.org\/10.1186\/s13578-024-01226-4.","journal-title":"Cell Biosci"},{"key":"1328_CR120","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103365","volume":"77","author":"Y Song","year":"2024","unstructured":"Song Y, Zhu M, Islam MA, et al. Glutathione peroxidase 3 is essential for countering senescence in adipose remodelling by maintaining mitochondrial homeostasis. Redox Biol. 2024;77:103365. https:\/\/doi.org\/10.1016\/j.redox.2024.103365.","journal-title":"Redox Biol"},{"key":"1328_CR121","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellin.2025.100252","volume":"4","author":"S Qiu","year":"2025","unstructured":"Qiu S, Wang Z, Guo S, et al. Single cell sequencing and spatial multiomics of diabetic kidney segmentation insights zonation-specific therapeutic metabolic pathways. Cell Insight. 2025;4:100252. https:\/\/doi.org\/10.1016\/j.cellin.2025.100252.","journal-title":"Cell Insight"},{"key":"1328_CR122","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1451084","volume":"15","author":"S Li","year":"2024","unstructured":"Li S, Hao L, Yu F, et al. Capsaicin: a spicy way in liver disease. Front Pharmacol. 2024;15:1451084. https:\/\/doi.org\/10.3389\/fphar.2024.1451084.","journal-title":"Front Pharmacol"},{"key":"1328_CR123","doi-asserted-by":"publisher","DOI":"10.1177\/1934578X1801301133","author":"M Martorell","year":"2018","unstructured":"Martorell M. Potential phytopharmacy and food applications of capsicum spp.: a comprehensive review. Nat Prod Commun. 2018. https:\/\/doi.org\/10.1177\/1934578X1801301133.","journal-title":"Nat Prod Commun"},{"key":"1328_CR124","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154067","volume":"100","author":"Z Liu","year":"2022","unstructured":"Liu Z, Wang W, Li X, et al. Capsaicin ameliorates renal fibrosis by inhibiting TGF-\u03b21-Smad2\/3 signaling. Phytomedicine. 2022;100:154067. https:\/\/doi.org\/10.1016\/j.phymed.2022.154067.","journal-title":"Phytomedicine"},{"key":"1328_CR125","doi-asserted-by":"publisher","first-page":"18769","DOI":"10.1021\/acs.jafc.3c05735","volume":"71","author":"X Zhu","year":"2023","unstructured":"Zhu X, Si F, Hao R, et al. Nuciferine protects against obesity-induced nephrotoxicity through its hypolipidemic, anti-inflammatory, and antioxidant effects. J Agric Food Chem. 2023;71:18769\u201379. https:\/\/doi.org\/10.1021\/acs.jafc.3c05735.","journal-title":"J Agric Food Chem"},{"key":"1328_CR126","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1111\/bcpt.13947","volume":"133","author":"E Tan","year":"2023","unstructured":"Tan E, Gao Z, Wang Q, et al. Berberine ameliorates renal interstitial inflammation and fibrosis in mice with unilateral ureteral obstruction. Basic Clin Pharmacol Toxicol. 2023;133:757\u201369. https:\/\/doi.org\/10.1111\/bcpt.13947.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"1328_CR127","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.7150\/thno.30640","volume":"9","author":"X Qin","year":"2019","unstructured":"Qin X, Zhao Y, Gong J, et al. Berberine protects glomerular podocytes via inhibiting Drp1-mediated mitochondrial fission and dysfunction. Theranostics. 2019;9:1698\u2013713. https:\/\/doi.org\/10.7150\/thno.30640.","journal-title":"Theranostics"},{"key":"1328_CR128","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1080\/13880209.2025.2543829","volume":"63","author":"W He","year":"2025","unstructured":"He W, Wei Z, Li S, et al. Uncovering the mechanistic basis of Rheum palmatum L. (rhubarb) in the treatment of chronic kidney disease: an integrative approach using network pharmacology, molecular docking, and experimental validation. Pharm Biol. 2025;63:582\u2013606. https:\/\/doi.org\/10.1080\/13880209.2025.2543829.","journal-title":"Pharm Biol."},{"key":"1328_CR129","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27072344","volume":"27","author":"X Song","year":"2022","unstructured":"Song X, Du Z, Yao Z, et al. Rhein improves renal fibrosis by restoring Cpt1a-mediated fatty acid oxidation through SirT1\/STAT3\/twist1 pathway. Molecules. 2022;27:2344. https:\/\/doi.org\/10.3390\/molecules27072344.","journal-title":"Molecules"},{"key":"1328_CR130","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154147","volume":"102","author":"Q Xiao","year":"2022","unstructured":"Xiao Q, Yu X, Yu X, et al. An integrated network pharmacology and cell metabolomics approach to reveal the role of rhein, a novel PPAR\u03b1 agonist, against renal fibrosis by activating the PPAR\u03b1\u2013CPT1A axis. Phytomedicine. 2022;102:154147. https:\/\/doi.org\/10.1016\/j.phymed.2022.154147.","journal-title":"Phytomedicine"},{"key":"1328_CR131","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6662704","volume":"2021","author":"J Liu","year":"2021","unstructured":"Liu J, Sun Y, Zheng H, et al. Emodin attenuated the kidney damage of high-fat-diet mice via the upregulation of glucagon-like peptide-1 receptor. BioMed Res Int. 2021;2021:6662704. https:\/\/doi.org\/10.1155\/2021\/6662704.","journal-title":"BioMed Res Int"},{"key":"1328_CR132","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/1896781","volume":"2022","author":"C Ji","year":"2022","unstructured":"Ji C, Lu F, Wu Y, et al. Rhubarb enema increasing short-chain fatty acids that improves the intestinal barrier disruption in CKD may be related to the regulation of gut dysbiosis. BioMed Res Int. 2022;2022:1896781. https:\/\/doi.org\/10.1155\/2022\/1896781.","journal-title":"BioMed Res Int"},{"key":"1328_CR133","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1002\/ptr.8085","volume":"38","author":"M Wang","year":"2024","unstructured":"Wang M, Wang J, Wang L, et al. Icariside II prevents kidney fibrosis development in chronic kidney disease by promoting fatty acid oxidation. Phytother Res. 2024;38:839\u201355. https:\/\/doi.org\/10.1002\/ptr.8085.","journal-title":"Phytother Res"},{"key":"1328_CR134","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.155162","volume":"122","author":"H Hu","year":"2024","unstructured":"Hu H, Li W, Hao Y, et al. Baicalin ameliorates renal fibrosis by upregulating CPT1\u03b1-mediated fatty acid oxidation in diabetic kidney disease. Phytomedicine. 2024;122:155162. https:\/\/doi.org\/10.1016\/j.phymed.2023.155162.","journal-title":"Phytomedicine"},{"key":"1328_CR135","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102957","volume":"68","author":"V Miguel","year":"2023","unstructured":"Miguel V, Rey-Serra C, Titua\u00f1a J, et al. Enhanced fatty acid oxidation through metformin and baicalin as therapy for COVID-19 and associated inflammatory states in lung and kidney. Redox Biol. 2023;68:102957. https:\/\/doi.org\/10.1016\/j.redox.2023.102957.","journal-title":"Redox Biol"},{"key":"1328_CR136","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1038\/s41401-023-01106-6","volume":"44","author":"T-F Zou","year":"2023","unstructured":"Zou T-F, Liu Z-G, Cao P-C, et al. Fisetin treatment alleviates kidney injury in mice with diabetes-exacerbated atherosclerosis through inhibiting CD36\/fibrosis pathway. Acta Pharmacol Sin. 2023;44:2065\u201374. https:\/\/doi.org\/10.1038\/s41401-023-01106-6.","journal-title":"Acta Pharmacol Sin"},{"key":"1328_CR137","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2023.110533","volume":"379","author":"S Liu","year":"2023","unstructured":"Liu S, Fu S, Jin Y, Geng R, et al. Tartary buckwheat flavonoids alleviates high-fat diet induced kidney fibrosis in mice by inhibiting MAPK and TGF-\u03b21\/smad signaling pathway. Chem-Biol Interact. 2023;379:110533. https:\/\/doi.org\/10.1016\/j.cbi.2023.110533.","journal-title":"Chem-Biol Interact"},{"key":"1328_CR138","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.107340","volume":"95","author":"Q Li","year":"2021","unstructured":"Li Q, Ge C, Tan J, et al. Juglanin protects against high fat diet-induced renal injury by suppressing inflammation and dyslipidemia via regulating NF-\u03baB\/HDAC3 signaling. Int Immunopharmacol. 2021;95:107340. https:\/\/doi.org\/10.1016\/j.intimp.2020.107340.","journal-title":"Int Immunopharmacol"},{"key":"1328_CR139","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.freeradbiomed.2017.06.009","volume":"110","author":"B Feng","year":"2017","unstructured":"Feng B, Meng R, Huang B, et al. Silymarin protects against renal injury through normalization of lipid metabolism and mitochondrial biogenesis in high fat-fed mice. Free Radical Biol Med. 2017;110:240\u20139. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2017.06.009.","journal-title":"Free Radical Biol Med"},{"key":"1328_CR140","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21020402","volume":"21","author":"Y Quan","year":"2020","unstructured":"Quan Y, Park W, Jin J, et al. Sirtuin 3 activation by honokiol decreases unilateral ureteral obstruction-induced renal inflammation and fibrosis via regulation of mitochondrial dynamics and the renal NF-\u03baBTGF-\u03b21\/smad signaling pathway. Int J Mol Sci. 2020;21:402. https:\/\/doi.org\/10.3390\/ijms21020402.","journal-title":"Int J Mol Sci"},{"key":"1328_CR141","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.taap.2019.03.007","volume":"370","author":"T Ma","year":"2019","unstructured":"Ma T, Zheng Z, Guo H, et al. 4-O-methylhonokiol ameliorates type 2 diabetes-induced nephropathy in mice likely by activation of AMPK-mediated fatty acid oxidation and Nrf2-mediated anti-oxidative stress. Toxicol Appl Pharmacol. 2019;370:93\u2013105. https:\/\/doi.org\/10.1016\/j.taap.2019.03.007.","journal-title":"Toxicol Appl Pharmacol"},{"key":"1328_CR142","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2022.174776","volume":"918","author":"W Gu","year":"2022","unstructured":"Gu W, Wang X, Zhao H, et al. Resveratrol ameliorates diabetic kidney injury by reducing lipotoxicity and modulates expression of components of the junctional adhesion molecule-like\/sirtuin 1 lipid metabolism pathway. Eur J Pharmacol. 2022;918:174776. https:\/\/doi.org\/10.1016\/j.ejphar.2022.174776.","journal-title":"Eur J Pharmacol"},{"key":"1328_CR143","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2022.115923","volume":"302","author":"Y Han","year":"2023","unstructured":"Han Y, Su Y, Han M, et al. Ginsenoside Rg1 attenuates glomerular fibrosis by inhibiting CD36\/TRPC6\/NFAT2 signaling in type 2 diabetes mellitus mice. J Ethnopharmacol. 2023;302:115923. https:\/\/doi.org\/10.1016\/j.jep.2022.115923.","journal-title":"J Ethnopharmacol"},{"key":"1328_CR144","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/9942152","volume":"2021","author":"J Gao","year":"2021","unstructured":"Gao J, Liu P, Shen Z, et al. Morroniside promotes PGC-1\u03b1-mediated cholesterol efflux in sodium palmitate or high glucose-induced mouse renal tubular epithelial cells. BioMed Res Int. 2021;2021:9942152. https:\/\/doi.org\/10.1155\/2021\/9942152.","journal-title":"BioMed Res Int"},{"key":"1328_CR145","doi-asserted-by":"publisher","first-page":"3539","DOI":"10.1093\/ndt\/gfq245","volume":"25","author":"Q Gao","year":"2010","unstructured":"Gao Q, Shen W, Qin W, et al. Treatment of db\/db diabetic mice with triptolide: a novel therapy for diabetic nephropathy. Nephrol Dial Transplant. 2010;25:3539\u201347. https:\/\/doi.org\/10.1093\/ndt\/gfq245.","journal-title":"Nephrol Dial Transplant"},{"key":"1328_CR146","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109702","volume":"125","author":"X Cheng","year":"2020","unstructured":"Cheng X, Qiu L, Wang F. 18\u03b1-glycyrrhetinic acid (GA) ameliorates fructose-induced nephropathy in mice by suppressing oxidative stress, dyslipidemia and inflammation. Biomed Pharmacother. 2020;125:109702. https:\/\/doi.org\/10.1016\/j.biopha.2019.109702.","journal-title":"Biomed Pharmacother"},{"key":"1328_CR147","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11101854","volume":"11","author":"AK Aranda-Rivera","year":"2022","unstructured":"Aranda-Rivera AK, Cruz-Gregorio A, Aparicio-Trejo OE, et al. Sulforaphane protects against unilateral ureteral obstruction-induced renal damage in rats by alleviating mitochondrial and lipid metabolism impairment. Antioxidants. 2022;11:1854. https:\/\/doi.org\/10.3390\/antiox11101854.","journal-title":"Antioxidants"},{"key":"1328_CR148","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.915592","volume":"13","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, Xiao X, Li M, et al. Bailing capsule (cordyceps sinensis) ameliorates renal triglyceride accumulation through the PPAR\u03b1 pathway in diabetic rats. Front Pharmacol. 2022;13:915592. https:\/\/doi.org\/10.3389\/fphar.2022.915592.","journal-title":"Front Pharmacol"},{"key":"1328_CR149","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.111098","volume":"134","author":"H Cai","year":"2021","unstructured":"Cai H, Wang J, Luo Y, et al. Lindera aggregata intervents adenine-induced chronic kidney disease by mediating metabolism and TGF-\u03b2\/smad signaling pathway. Biomed Pharmacother. 2021;134:111098. https:\/\/doi.org\/10.1016\/j.biopha.2020.111098.","journal-title":"Biomed Pharmacother"},{"key":"1328_CR150","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.3390\/cimb45020078","volume":"45","author":"NS Younis","year":"2023","unstructured":"Younis NS. Myrrh essential oil mitigates renal ischemia\/reperfusion-induced injury. Curr Issues Mol Biol. 2023;45:1183\u201396. https:\/\/doi.org\/10.3390\/cimb45020078.","journal-title":"Curr Issues Mol Biol"},{"key":"1328_CR151","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2022.109846","volume":"354","author":"M Liu","year":"2022","unstructured":"Liu M, Wang W, Wang J, et al. Z-guggulsterone alleviates renal fibrosis by mitigating G2\/M cycle arrest through klotho\/p53 signaling. Chem Biol Interact. 2022;354:109846. https:\/\/doi.org\/10.1016\/j.cbi.2022.109846.","journal-title":"Chem Biol Interact"},{"key":"1328_CR152","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1007\/s40200-021-00904-1","volume":"20","author":"M Hassanzadeh-Taheri","year":"2021","unstructured":"Hassanzadeh-Taheri M, Salimi M, Vazifeshenas-Darmiyan K, et al. Investigating the effect of ethanolic extract of commiphora myrrha (Nees) Engl. gum-resin against hepatorenal injury in diabetic rats. J Diabetes Metab Disord. 2021;20:1573\u201381. https:\/\/doi.org\/10.1007\/s40200-021-00904-1.","journal-title":"J Diabetes Metab Disord"},{"key":"1328_CR153","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2025.2524528","volume":"47","author":"Y Yan","year":"2025","unstructured":"Yan Y, Shi H, Li Y, et al. Mechanism of rhizoma chuanxiong for the treatment of diabetic kidney disease based on network pharmacology. Ren Fail. 2025;47:2524528. https:\/\/doi.org\/10.1080\/0886022X.2025.2524528.","journal-title":"Ren Fail"},{"key":"1328_CR154","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jpba.2013.03.028","volume":"81\u201382","author":"Y-Y Zhao","year":"2013","unstructured":"Zhao Y-Y, Lei P, Chen D-Q, et al. Renal metabolic profiling of early renal injury and renoprotective effects of poria cocos epidermis using UPLC Q-TOF\/HSMS\/MSE. J Pharm Biomed Anal. 2013;81\u201382:202\u20139. https:\/\/doi.org\/10.1016\/j.jpba.2013.03.028.","journal-title":"J Pharm Biomed Anal"},{"key":"1328_CR155","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154767","volume":"114","author":"B Liu","year":"2023","unstructured":"Liu B, Jie X, Deng J, et al. Bupi yishen formula may prevent kidney fibrosis by modulating fatty acid metabolism in renal tubules. Phytomedicine. 2023;114:154767. https:\/\/doi.org\/10.1016\/j.phymed.2023.154767.","journal-title":"Phytomedicine"},{"key":"1328_CR156","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2021.114699","volume":"283","author":"L Sun","year":"2022","unstructured":"Sun L, Yang Z, Zhao W, et al. Integrated lipidomics, transcriptomics and network pharmacology analysis to reveal the mechanisms of danggui buxue decoction in the treatment of diabetic nephropathy in type 2 diabetes mellitus. J Ethnopharmacol. 2022;283:114699. https:\/\/doi.org\/10.1016\/j.jep.2021.114699.","journal-title":"J Ethnopharmacol"},{"key":"1328_CR157","doi-asserted-by":"publisher","DOI":"10.1186\/s12906-023-04029-1","volume":"23","author":"Y Chen","year":"2023","unstructured":"Chen Y, Rui R, Wang L, et al. Huangqi decoction ameliorates kidney injury in db\/db mice by regulating the BMP\/smad signaling pathway. BMC Complement Med Ther. 2023;23:209. https:\/\/doi.org\/10.1186\/s12906-023-04029-1.","journal-title":"BMC Complement Med Ther"},{"key":"1328_CR158","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-32115-9","volume":"8","author":"S Li","year":"2018","unstructured":"Li S, Xiao X, Han L, et al. Renoprotective effect of zhenwu decoction against renal fibrosis by regulation of oxidative damage and energy metabolism disorder. Sci Rep. 2018;8:14627. https:\/\/doi.org\/10.1038\/s41598-018-32115-9.","journal-title":"Sci Rep"},{"key":"1328_CR159","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.12122\/j.issn.1673-4254.2025.09.07","volume":"45","author":"Q Hu","year":"2025","unstructured":"Hu Q, Jin H. Qingshen\u2002granules improves renal function of patients with chronic kidney disease damp-heat syndrome by activating the miR-23b and Nrf2 pathway. Nan Fang Yi Ke Da Xue Xue Bao. 2025;45:1867\u201379. https:\/\/doi.org\/10.12122\/j.issn.1673-4254.2025.09.07.","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"1328_CR160","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.156148","volume":"135","author":"W-J Zhou","year":"2024","unstructured":"Zhou W-J, Liang W, Hu M-X, et al. Qingshen granules inhibits dendritic cell glycolipid metabolism to alleviate renal fibrosis via PI3K-AKT-mTOR pathway. Phytomedicine. 2024;135:156148. https:\/\/doi.org\/10.1016\/j.phymed.2024.156148.","journal-title":"Phytomedicine"},{"key":"1328_CR161","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.12122\/j.issn.1673-4254.2024.08.01","volume":"44","author":"R Dai","year":"2024","unstructured":"Dai R, Cao Z, Liu C, et al. qingshen granules alleviates renal fibrosis in mice by regulating exosomes, miR-330\u20133p, and CREBBP expression. Nan Fang Yi Ke Da Xue Xue Bao. 2024;44:1431\u201340. https:\/\/doi.org\/10.12122\/j.issn.1673-4254.2024.08.01.","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao."},{"key":"1328_CR162","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/2793823","volume":"2021","author":"P Liu","year":"2021","unstructured":"Liu P, Wang C, Wang Y, et al. Zishen qingre tongluo formula improves renal fatty acid oxidation and alleviated fibrosis via the regulation of the TGF-\u03b21\/Smad3 signaling pathway in hyperuricemic nephrology rats. Biomed Res Int. 2021;2021:2793823. https:\/\/doi.org\/10.1155\/2021\/2793823.","journal-title":"Biomed Res Int"},{"key":"1328_CR163","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/6275505","volume":"2022","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Yao H, Li C, et al. Gandi capsule improved podocyte lipid metabolism of diabetic nephropathy mice through SIRT1\/AMPK\/HNF4A pathway. Oxid Med Cell Longev. 2022;2022:6275505. https:\/\/doi.org\/10.1155\/2022\/6275505.","journal-title":"Oxid Med Cell Longev"},{"key":"1328_CR164","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1491315","volume":"15","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Jia Q, Hao G, et al. Jiangyatongluo decoction ameliorates tubulointerstitial fibrosis via regulating the SIRT1\/PGC-1\u03b1\/mitophagy axis in hypertensive nephropathy. Front Pharmacol. 2024;15:1491315. https:\/\/doi.org\/10.3389\/fphar.2024.1491315.","journal-title":"Front Pharmacol"},{"key":"1328_CR165","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111806","volume":"141","author":"W Zheng","year":"2021","unstructured":"Zheng W, Qian C, Xu F, et al. Fuxin granules ameliorate diabetic nephropathy in db\/db mice through TGF-\u03b21\/smad and VEGF\/VEGFR2 signaling pathways. Biomed Pharmacother. 2021;141:111806. https:\/\/doi.org\/10.1016\/j.biopha.2021.111806.","journal-title":"Biomed Pharmacother"},{"key":"1328_CR166","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155450","volume":"126","author":"M Wang","year":"2024","unstructured":"Wang M, Wang L, Zhou L, et al. Shen-shuai-II-recipe inhibits tubular inflammation by PPAR\u03b1-mediated fatty acid oxidation to attenuate fibroblast activation in fibrotic kidneys. Phytomedicine. 2024;126:155450. https:\/\/doi.org\/10.1016\/j.phymed.2024.155450.","journal-title":"Phytomedicine"},{"key":"1328_CR167","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2024.2356021","volume":"46","author":"L Chen","year":"2024","unstructured":"Chen L, Wang Q, Li T, et al. Exploring therapeutic mechanisms of chuan huang fang-II in the treatment of acute kidney injury on chronic kidney disease patients from the perspective of lipidomics. Ren Fail. 2024;46:2356021. https:\/\/doi.org\/10.1080\/0886022X.2024.2356021.","journal-title":"Ren Fail"},{"key":"1328_CR168","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1080\/0886022X.2021.1944875","volume":"43","author":"X Xu","year":"2021","unstructured":"Xu X, Wang H, Guo D, et al. Curcumin modulates gut microbiota and improves renal function in rats with uric acid nephropathy. Ren Fail. 2021;43:1063\u201375. https:\/\/doi.org\/10.1080\/0886022X.2021.1944875.","journal-title":"Ren Fail"},{"key":"1328_CR169","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115434","volume":"166","author":"J Wang","year":"2023","unstructured":"Wang J, Guo X, Zou Z, et al. Ootheca mantidis mitigates renal fibrosis in mice by the suppression of apoptosis via increasing the gut microbe akkermansia muciniphila and modulating glutamine metabolism. Biomed Pharmacother. 2023;166:115434. https:\/\/doi.org\/10.1016\/j.biopha.2023.115434.","journal-title":"Biomed Pharmacother"},{"key":"1328_CR170","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.138629","volume":"289","author":"Q Fu","year":"2025","unstructured":"Fu Q, Yang Y, Tian Q, et al. Exploring the mechanism of paotianxiong polysaccharide in the treatment of chronic kidney disease combining metabolomics and microbiomics technologies. Int J Biol Macromol. 2025;289:138629. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.138629.","journal-title":"Int J Biol Macromol"},{"key":"1328_CR171","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2020.113768","volume":"269","author":"C Han","year":"2021","unstructured":"Han C, Jiang Y-H, Li W, et al. Astragalus membranaceus and Salvia miltiorrhiza ameliorates cyclosporin A-induced chronic nephrotoxicity through the \u201cgut-kidney axis.\u201d J Ethnopharmacol. 2021;269:113768. https:\/\/doi.org\/10.1016\/j.jep.2020.113768.","journal-title":"J Ethnopharmacol"},{"key":"1328_CR172","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.155129","volume":"121","author":"Z Shen","year":"2023","unstructured":"Shen Z, Cui T, Liu Y, et al. Astragalus membranaceus and Salvia miltiorrhiza ameliorate diabetic kidney disease via the \u201cgut-kidney axis.\u201d Phytomedicine. 2023;121:155129. https:\/\/doi.org\/10.1016\/j.phymed.2023.155129.","journal-title":"Phytomedicine"},{"key":"1328_CR173","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/5418796","volume":"2019","author":"C Han","year":"2019","unstructured":"Han C, Jiang Y-H, Li W, et al. Study on the antihypertensive mechanism of astragalus membranaceus and salvia miltiorrhiza based on intestinal flora-host metabolism. Evid Based Complement Alternat Med. 2019;2019:1\u201316. https:\/\/doi.org\/10.1155\/2019\/5418796.","journal-title":"Evid Based Complement Alternat Med"},{"key":"1328_CR174","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1518481","volume":"16","author":"C Han","year":"2025","unstructured":"Han C, Gao R-R, Zhou L, et al. The gut-kidney axis is regulated by astragaloside IV to inhibit cyclosporine a-induced nephrotoxicity. Front Pharmacol. 2025;16:1518481. https:\/\/doi.org\/10.3389\/fphar.2025.1518481.","journal-title":"Front Pharmacol"},{"key":"1328_CR175","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2024.151174","volume":"744","author":"Y Xing","year":"2025","unstructured":"Xing Y, Huang D, Lin P, et al. Salvianolic acid C promotes renal gluconeogenesis in fibrotic kidneys through PGC1\u03b1. Biochem Biophys Res Commun. 2025;744:151174. https:\/\/doi.org\/10.1016\/j.bbrc.2024.151174.","journal-title":"Biochem Biophys Res Commun"},{"key":"1328_CR176","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2025.119364","volume":"342","author":"Y Peng","year":"2025","unstructured":"Peng Y, Wu S, Xu Y, et al. Huangqi-danshen decoction alleviates renal fibrosis through targeting SCD1 to modulate cGAS\/STING signaling. J Ethnopharmacol. 2025;342:119364. https:\/\/doi.org\/10.1016\/j.jep.2025.119364.","journal-title":"J Ethnopharmacol"},{"key":"1328_CR177","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.116257","volume":"307","author":"C Han","year":"2023","unstructured":"Han C, Shen Z, Cui T, et al. Yi-shen-hua-shi granule ameliorates diabetic kidney disease by the \u201cgut-kidney axis.\u201d J Ethnopharmacol. 2023;307:116257. https:\/\/doi.org\/10.1016\/j.jep.2023.116257.","journal-title":"J Ethnopharmacol"},{"key":"1328_CR178","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1111\/1751-7915.14200","volume":"16","author":"R Shi","year":"2022","unstructured":"Shi R, Tao Y, Tang H, et al. Abelmoschus manihot ameliorates the levels of circulating metabolites in diabetic nephropathy by modulating gut microbiota in non-obese diabetes mice. Microb Biotechnol. 2022;16:813\u201326. https:\/\/doi.org\/10.1111\/1751-7915.14200.","journal-title":"Microb Biotechnol"},{"key":"1328_CR179","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154935","volume":"118","author":"T Lan","year":"2023","unstructured":"Lan T, Tang T, Li Y, et al. FTZ polysaccharides ameliorate kidney injury in diabetic mice by regulating gut-kidney axis. Phytomedicine. 2023;118:154935. https:\/\/doi.org\/10.1016\/j.phymed.2023.154935.","journal-title":"Phytomedicine"},{"key":"1328_CR180","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00759-22","volume":"10","author":"Y-T Zou","year":"2022","unstructured":"Zou Y-T, Zhou J, Zhu J-H, et al. Gut microbiota mediates the protective effects of traditional Chinese medicine formula qiong-yu-gao against cisplatin-induced acute kidney injury. Microbiol Spectr. 2022;10:e0075922. https:\/\/doi.org\/10.1128\/spectrum.00759-22.","journal-title":"Microbiol Spectr"},{"key":"1328_CR181","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.849832","volume":"13","author":"J Zou","year":"2022","unstructured":"Zou J, Zhou X, Chen X, et al. Shenkang injection for treating renal fibrosis-metabonomics and regulation of E3 ubiquitin ligase smurfs on TGF-\u03b2\/smads signal transduction. Front Pharmacol. 2022;13:849832. https:\/\/doi.org\/10.3389\/fphar.2022.849832.","journal-title":"Front Pharmacol"},{"key":"1328_CR182","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.13703\/j.0255-2930.20200907-0005","volume":"41","author":"J-Y Mao","year":"2021","unstructured":"Mao J-Y, Yang F-W, Liu H, et al. effect of moxibustion on renal function and hypercoagulable state in patients with idiopathic membranous nephropathy of low to medium risk with spleen-kidney deficiency and blood stasis. Zhongguo Zhen Jiu. 2021;41:1216\u201320. https:\/\/doi.org\/10.13703\/j.0255-2930.20200907-0005.","journal-title":"Zhongguo Zhen Jiu"},{"key":"1328_CR183","first-page":"875","volume":"27","author":"Z-L Zhang","year":"2007","unstructured":"Zhang Z-L, Ji X-Q, Zhang P, et al. randomized and controlled study on needling method of harmonizing spleen-stomach for early intervention of diabetic nephropathies and the mechanism of protecting kidney. Zhongguo Zhen Jiu. 2007;27:875\u201380.","journal-title":"Zhongguo Zhen Jiu"},{"key":"1328_CR184","first-page":"894","volume":"34","author":"G Zhang","year":"2014","unstructured":"Zhang G, Miao J, Zhang Z-Y, et al. regulation effects of electroacupuncture with different acupoint combinations on blood lipid in rats with hyperlipemia. Zhongguo Zhen Jiu. 2014;34:894\u20137.","journal-title":"Zhongguo Zhen Jiu"},{"key":"1328_CR185","first-page":"139","volume":"30","author":"Y Tang","year":"2024","unstructured":"Tang Y, Yang J, Wang J, et al. Effects of acupuncture combined with yi qi yang yin and blood activating formula on blood glucose and renal function in early diabetic nephropathy: A randomized controlled trial. Altern Ther Health Med. 2024;30:139\u201343.","journal-title":"Altern Ther Health Med"},{"key":"1328_CR186","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.explore.2022.01.001","volume":"18","author":"H-K Jung","year":"2022","unstructured":"Jung H-K, Lai T-H, Lai J-N, et al. Preserving residual renal function: is interdialytic acupuncture an add-on option? A case series report. EXPLORE. 2022;18:710\u20133. https:\/\/doi.org\/10.1016\/j.explore.2022.01.001.","journal-title":"EXPLORE"},{"key":"1328_CR187","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2025.2496410","volume":"57","author":"A Lu","year":"2025","unstructured":"Lu A, Wang M, Jiang N, et al. Electroacupuncture versus sham for insomnia in patients undergoing maintenance hemodialysis: study protocol for a pilot randomized controlled trial. Ann Med. 2025;57:2496410. https:\/\/doi.org\/10.1080\/07853890.2025.2496410.","journal-title":"Ann Med"},{"key":"1328_CR188","doi-asserted-by":"publisher","DOI":"10.1016\/j.actpsy.2025.104728","volume":"253","author":"X Yu","year":"2025","unstructured":"Yu X, Hua S, Jin E, et al. Improving hemodialysis patient depression outcomes with acupuncture: a randomized controlled trial. Acta Psychol (Amst). 2025;253:104728. https:\/\/doi.org\/10.1016\/j.actpsy.2025.104728.","journal-title":"Acta Psychol (Amst)"},{"key":"1328_CR189","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.3892\/mmr.2019.10470","volume":"20","author":"Z Zuo","year":"2019","unstructured":"Zuo Z, Huang P, Jiang Y, et al. Acupuncture attenuates renal interstitial fibrosis via the TGF-\u03b2\/smad pathway. Mol Med Rep. 2019;20:2267\u201375. https:\/\/doi.org\/10.3892\/mmr.2019.10470.","journal-title":"Mol Med Rep"},{"key":"1328_CR190","doi-asserted-by":"publisher","first-page":"84","DOI":"10.13702\/j.1000-0607.20230764","volume":"50","author":"J-M Chen","year":"2025","unstructured":"Chen J-M, Du Y-J, Tian Q, et al. effect of electroacupuncture on renal aging and renal phosphatidylinositide 3-kinase\/protein kinase B signaling in aging mice. Zhen Ci Yan Jiu. 2025;50:84\u20139. https:\/\/doi.org\/10.13702\/j.1000-0607.20230764.","journal-title":"Zhen Ci Yan Jiu."},{"key":"1328_CR191","doi-asserted-by":"publisher","first-page":"435","DOI":"10.13702\/j.1000-0607.20210381","volume":"47","author":"K-X Wang","year":"2022","unstructured":"Wang K-X, Liang F-X, Chen S, et al. Electroacupuncture of \u201cbiaoben acupoints\u201d relieves kidney injury by suppressing oxidative stress in diabetic nephropathy rats. Zhen Ci Yan Jiu. 2022;47:435\u201342. https:\/\/doi.org\/10.13702\/j.1000-0607.20210381.","journal-title":"Zhen Ci Yan Jiu."},{"key":"1328_CR192","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.13702\/j.1000-0607.20231021","volume":"49","author":"K-X Wang","year":"2024","unstructured":"Wang K-X, Wan M, Zhu X-L, et al. electroacupuncture preconditioning alleviates podocyte injury via PTEN\/PI3K pathway in type 2 diabetes rats. Zhen Ci Yan Jiu. 2024;49:1257\u201365. https:\/\/doi.org\/10.13702\/j.1000-0607.20231021.","journal-title":"Zhen Ci Yan Jiu."},{"key":"1328_CR193","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000028082","volume":"100","author":"Z Wang","year":"2021","unstructured":"Wang Z, Zhang S, Zheng X, et al. Efficacy and safety of colonic dialysis combined with traditional Chinese medicine retention enema in the treatment of chronic renal failure: a protocol for systematic review and meta-analysis. Medicine (Baltimore). 2021;100:e28082. https:\/\/doi.org\/10.1097\/MD.0000000000028082.","journal-title":"Medicine (Baltimore)"},{"key":"1328_CR194","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1246852","volume":"14","author":"Y Deng","year":"2024","unstructured":"Deng Y, Zhang L, Chen S, et al. Exploring the clinical efficacy and mechanism of high-position colon dialysis combined with traditional Chinese medicine retention enema in real-world patients with stage 3-5 chronic kidney disease (non-dialysis) based on the theory of the gut-kidney axis. Front Pharmacol. 2024;14:1246852. https:\/\/doi.org\/10.3389\/fphar.2023.1246852.","journal-title":"Front Pharmacol"},{"key":"1328_CR195","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1453668","volume":"15","author":"Y Ye","year":"2025","unstructured":"Ye Y, Huang X, Li X, et al. Shenshuaikang enema restores the intestinal barrier and microbiota-gut-kidney axis balance to alleviate chronic kidney disease via NF-\u03baB pathway. Front Pharmacol. 2025;15:1453668. https:\/\/doi.org\/10.3389\/fphar.2024.1453668.","journal-title":"Front Pharmacol"},{"key":"1328_CR196","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s11655-009-0431-2","volume":"15","author":"Q Chen","year":"2009","unstructured":"Chen Q, Ma L, Akebaier W. Clinical study on treatment of hyperuricaemia by retention enema of Chinese herbal medicine combined with allopurinol. Chin J Integr Med. 2009;15:431\u20134. https:\/\/doi.org\/10.1007\/s11655-009-0431-2.","journal-title":"Chin J Integr Med"},{"key":"1328_CR197","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.5508","volume":"37","author":"H Wang","year":"2022","unstructured":"Wang H, Wang Z, Jiang M, et al. Pharmacokinetics and tissue distribution of five bioactive components in the corydalis yanhusuo total alkaloids transdermal patch following shenque acupoint application in rats assessed by ultra-performance liquid chromatography-tandem mass spectrometry. Biomed Chromatogr. 2022;37:e5508. https:\/\/doi.org\/10.1002\/bmc.5508.","journal-title":"Biomed Chromatogr"},{"key":"1328_CR198","doi-asserted-by":"publisher","first-page":"411","DOI":"10.13702\/j.1000-0607.200708","volume":"46","author":"J-N Liu","year":"2021","unstructured":"Liu J-N, Tang X-Q, He X-Q, et al. effect of application at shu-mu acupoint on serum uric acid in hyperuricemic rats. Zhen Ci Yan Jiu. 2021;46:411\u20135. https:\/\/doi.org\/10.13702\/j.1000-0607.200708.","journal-title":"Zhen Ci Yan Jiu"},{"key":"1328_CR199","doi-asserted-by":"publisher","DOI":"10.1097\/jnr.0000000000000378","volume":"28","author":"ES Jung","year":"2020","unstructured":"Jung ES, Chang AK. Effects of auricular acupressure in patients on hemodialysis. J Nurs Res. 2020;28:e106. https:\/\/doi.org\/10.1097\/jnr.0000000000000378.","journal-title":"J Nurs Res"},{"key":"1328_CR200","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-018-2546-2","volume":"19","author":"Y Wu","year":"2018","unstructured":"Wu Y, Yang L, Li L, et al. Auricular acupressure for insomnia in hemodialysis patients: study protocol for a randomized controlled trial. Trials. 2018;19:171. https:\/\/doi.org\/10.1186\/s13063-018-2546-2.","journal-title":"Trials"},{"key":"1328_CR201","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.141464","volume":"306","author":"Y Zhao","year":"2025","unstructured":"Zhao Y, Ding Q, He Q, et al. Reno protective potential of taxifolin liposomes modified by chitosan in diabetic mice. Int J Biol Macromol. 2025;306:141464. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.141464.","journal-title":"Int J Biol Macromol"},{"key":"1328_CR202","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154110","volume":"101","author":"Z Xu","year":"2022","unstructured":"Xu Z, Hou Y, Sun J, et al. Deoxycholic acid-chitosan coated liposomes combined with in situ colonic gel enhances renal fibrosis therapy of emodin. Phytomedicine. 2022;101:154110. https:\/\/doi.org\/10.1016\/j.phymed.2022.154110.","journal-title":"Phytomedicine"},{"key":"1328_CR203","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2024.102607","volume":"61","author":"X Liu","year":"2025","unstructured":"Liu X, Dong J, Cui J, et al. Microalgae-based drug delivery microspheres for treatment of hyperuricemia with renal injury. Nano Today. 2025;61:102607. https:\/\/doi.org\/10.1016\/j.nantod.2024.102607.","journal-title":"Nano Today"},{"key":"1328_CR204","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2025.101901","volume":"32","author":"Y Meng","year":"2025","unstructured":"Meng Y, Han D, Xiang J, et al. Self-assembled vectors derived from aster tataricus L.f. mitigate bleomycin-induced pulmonary fibrosis in mice. Mater Today Bio. 2025;32:101901. https:\/\/doi.org\/10.1016\/j.mtbio.2025.101901.","journal-title":"Mater Today Bio"},{"key":"1328_CR205","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/s41581-024-00819-z","volume":"20","author":"Y Huang","year":"2024","unstructured":"Huang Y, Ning X, Ahrari S, et al. Physiological principles underlying the kidney targeting of renal nanomedicines. Nat Rev Nephrol. 2024;20:354\u201370. https:\/\/doi.org\/10.1038\/s41581-024-00819-z.","journal-title":"Nat Rev Nephrol"},{"key":"1328_CR206","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2025.123738","volume":"327","author":"M Liu","year":"2026","unstructured":"Liu M, Li X, Gao Y, et al. Breaking the fibrotic code: nanotechnology-driven advances in renal fibrosis therapy. Biomaterials. 2026;327:123738. https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123738.","journal-title":"Biomaterials"}],"container-title":["Chinese Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-026-01328-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13020-026-01328-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-026-01328-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T07:29:29Z","timestamp":1768980569000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13020-026-01328-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":206,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1328"],"URL":"https:\/\/doi.org\/10.1186\/s13020-026-01328-w","relation":{},"ISSN":["1749-8546"],"issn-type":[{"value":"1749-8546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"assertion":[{"value":"24 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"45"}}